Mirae Asset Global Investments
KYTX icon

Mirae Asset Global Investments’s Kyverna Therapeutics KYTX Stock Holding History

Mirae Asset Global Investments’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2K Sell
2,719
-261
-9% -$2.32K ﹤0.01% 1463
2026
Q1 		$25.7K Buy
2,980
+852
+40% +$7.1K ﹤0.01% 1398
2025
Q4 		$20K Buy
2,128
+456
+27% +$3.38K ﹤0.01% 1534
2025
Q3 		$10K Buy
1,672
+2
+0.1% +$8 ﹤0.01% 1575
2025
Q2 		$5.13K Buy
1,670
+225
+16% +$557 ﹤0.01% 1539
2025
Q1 		$2.89K Buy
1,445
+6
+0.4% +$18 ﹤0.01% 1529
2024
Q4 		$5.74K Buy
+1,439
New +$6.89K ﹤0.01% 1551

Other funds holding KYTX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
SIC
Samalin Investment Counsel Chappaqua, New York $320M AUM 20.87% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Mirae Asset Global Investments's KYTX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Kyverna Therapeutics (KYTX) stake by 8.8% in Q2 2026, selling an estimated $2.32K and leaving 2,719 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1463.

Mirae Asset Global Investments first reported a position in KYTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.7K in Q1 2026. 21 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Mirae Asset Global Investments held 2,719 shares of Kyverna Therapeutics worth $24.2K as of Q2 2026.
  • Mirae Asset Global Investments sold 261 Kyverna Therapeutics shares in Q2 2026, an estimated $2.32K.
  • Kyverna Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1463 holding.
  • Mirae Asset Global Investments first reported a position in Kyverna Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's Kyverna Therapeutics position peaked at $25.7K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.